Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
BLOG
EVENT CALENDAR
COLUMNS
WHITE PAPERS
THE MAGAZINE
  Pharmaceutical Technology Europe E-Alert
 
2 November 2012

IN THIS ISSUE
• Q3 finances
• Patheon and Banner Pharmacaps
• Adalimumab biosimilar
• FDA 483
• Twitter

Third-Quarter 2012 Financial Reports Show Novartis and Merck Down
Pharmaceutical industry leaders Novartis and Merck—among others—released second-quarter 2012 results showing global sales down in third-quarter 2012, although growth in key pharmaceutical products helped to offset some losses from patent expirations. More...
 
Patheon to Acquire Banner Pharmacaps
Patheon will acquire softgel-specialist company Banner Pharmacaps, based in North Carolina in the US, for $255 million. More...
 
AET BioTech and BioXpress Therapeutics to Codevelop Adalimumab Biosimilar
AET BioTech and BioXpress Therapeutics have entered into an agreement to codevelop a biosimilar version of Abbott's tumor necrosis factor inhibitor monoclonal antibody adalimumab, currently marketed under the trade name Humira. More...
 
FDA Issues 483 to New England Compounding Center
The FDA has released a copy of a Form 483 issued to the New England Compounding Center, which has been under investigation in the US for contaminated products and violations of the Federal Food, Drug and Cosmetic Act. More...
 
Get the Latest Updates on Twitter
We regularly tweet the latest news and rumours hitting the web about the pharmaceutical industry. Follow us to keep up to date. More...
Key Topics:

Latest blog posts
Third-Quarter Revenues Wounded by Patent Expiries
FDA 483 Issues in the Calm Before the Storm
Purdue Pharma Issues Grant to NASCSA to Combat Abuse and Diversion of Prescription Medications
More blog posts

Latest articles
Uniformity of Dosage Units Using Large Sample Sizes
Combination Drugs: Adding Up the Opportunities
FDA and the Importance of Confidentiality
More articles

Upcoming events
BioEurope 2012 (12–14 November | Germany)
PDA FDA Pharmaceutical Supply Chain Conference (13–14 November | USA)
Asia Pharma R&D Outsourcing Congress (26–27 November | UK)
More events

Products/Service Profiles
Nippon Soda Co., Ltd.

Nisso HPC (hydroxypropyl cellulose)
Special low viscosity, super fine powder grade Nisso HPC-SSL-SFP is introduced as a new high performance dry binder for direct compression, ODT and extra-granule addition applications. Read More

Event profile

Lab Innovations
LAB INNOVATIONS 2012 is the UK's only dedicated showcase for laboratory technology and consumable, analytical and biotech equipment.Read More

Survey
Concerns have recently been raised about the safety of confidential data at FDA. Do you think regulators are doing enough to protect confidential data?
 
Yes 38%
 
 
No 63%

This week we would like to know...

2012 has been touted as a crucial year of the so-called patent cliff. Do you think the impact of patent expiries has been better or worse than expected?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.